CPBIO(03839.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 9.42 million, YoY decrease of 44.72%
NewTimeSpace News: August 11, 2026, CPBIO(03839.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 211.39 million, decreased by 34.62% YoY; Net Profit stood at USD 10.15 million, YoY decrease of 49.23%; Profit Attributable to Shareholders stood at USD 9.42 million, YoY decrease of 44.72%; Basic Earnings Per Share (EPS) stood at US cents 3.7.
In terms of profitability, CPBIO Gross Profit changed from USD 41.78 million in the same period last year to USD 34.73 million in the current period, decreased by USD 7.06 million; gross profit margin changed from 12.92% in the same period last year to 16.43% in the current period, increased by 3.51 percentage points; net profit changed from USD 19.99 million in the same period last year to USD 10.15 million in the current period, decreased by USD 9.84 million; net profit margin changed from 6.18% in the same period last year to 4.8% in the current period, decreased by 1.38 percentage points.
In terms of earnings quality, CPBIO Operating Profit changed from USD 23.13 million in the same period last year to USD 13.09 million in the current period, decreased by USD 10.04 million; Operating Profit Margin changed from 7.15% in the same period last year to 6.19% in the current period, decreased by 0.96 percentage points.
In terms of financial soundness, CPBIO Debt-to-Asset Ratio changed from 36.48% in the same period last year to 35.44% in the current period, decreased by 1.04 percentage points; Total Equity changed from USD 284.905 million in the same period last year to USD 326.273 million in the current period, increased by USD 41.37 million; Current Liabilities changed from USD 147.04 million in the same period last year to USD 161.05 million in the current period, increased by USD 14.01 million; Quick Ratio changed from 1.32 in the same period last year to 1.36 in the current period, increased by 0.04 percentage points.
By the close of trading on August 11, 2026, CPBIO(03839) saw a loss of 1.38% in its share price, closing at HKD 8.58. The full-day turnover stood at HKD 245.88 thousand, with the latest market capitalization at HKD 2.07 billion.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
